A carregar...
Lupeol, a Novel Androgen Receptor Inhibitor: Implications in Prostate Cancer Therapy
PURPOSE: Conventional therapies to treat prostate cancer (CaP) of androgen-dependent phenotype (ADPC) and castration resistant phenotype (CRPC) are deficient in outcome which has necessitated a need to identify agents those could target AR for both disease types. We provide mechanism-based evidence...
Na minha lista:
| Publicado no: | Clin Cancer Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4573593/ https://ncbi.nlm.nih.gov/pubmed/21712449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0916 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|